Evidence map›Paper›PMID 42453681›Full record

ArticleFrontiers in digital health2026

Real-world evidence on data quality in precision oncology platforms: insights from the Molecular Twin Research Umbrella protocol.

Michael Zuniga, Denis Marino, Yuan Yuan, Jin Sun Lee, Nazelee Dagliyan, Dominique Pope, Gangothri Namasivayam, Hui Hong, Grant Dagliyan, Warren G Tourtellotte and 2 more

Abstract read
In one paragraph

Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Michael Zuniga *OncoBiobank Shared Resource, Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Denis Marino *OncoBiobank Shared Resource, Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Yuan YuanSamuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Jin Sun LeeSamuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Nazelee DagliyanOncoBiobank Shared Resource, Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Dominique PopeOncoBiobank Shared Resource, Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Gangothri NamasivayamSamuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Hui HongSamuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Grant DagliyanSamuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Warren G TourtellotteOncoBiobank Shared Resource, Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Robert FiglinSamuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Karine SargsyanOncoBiobank Shared Resource, Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increase in precision oncology largely relies on the availability of high-quality, longitudinal, and multi-source, multi-purpose, and multidimensional corresponding data that integrate clinical, pathological, and molecular information. While new and advanced biomedical methods enable large-scale data generation, the operational challenges associated with data retrieval, harmonization, and quality control remain insufficiently described in scientific literature. In parallel, data incompleteness and heterogeneity in collection practices and coding standards are diminishing confidence in precision medicine programs. This methodological case study focused on the challenges of data harmonization within the Molecular Twin Research Umbrella Protocol at Cedars-Sinai Medical Center. This systematic four-stage process includes requirements for data access and assembly, processing for cleaning and harmonization, and quality verification before distribution. Pairwise comparisons have been made for each type of record, from electronic health records through cancer registration and biobanking. The demographics showed a very high concordance (>95%), whereas the clinically essential variables, such as tumor TNM stage, diagnostic specificity, and intervention schedules, showed moderate discordance (14.8%-17%). These discrepancies are a significant hindrance to the readiness of the cohorts for prediction models. Based on these results, we propose mitigation strategies aimed at improving the accuracy, completeness, and standardization of longitudinal oncology cohort datasets. This study provides key recommendations for long-term oncology cohorts and for the development of digital twin infrastructure for any institution, stressing that sound data quality infrastructure is a cornerstone of trustworthy precision oncology and translational research.

Indexed as

biobanking infrastructurebiospecimen corresponding data qualitydata harmonizationdata quality and governanceelectronic health records (EHR)longitudinal cancer cohortslongitudinal studyprecision medicine

Identifiers

PMID42453681
PMCPMC13365115

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.